INIS
india
100%
covid-19
56%
diseases
52%
fibers
33%
patients
31%
transmission
30%
drugs
29%
mycobacterium
28%
therapy
26%
pcr
25%
strains
22%
comparative evaluations
22%
testing
21%
biological markers
19%
coronaviruses
19%
pools
19%
waste water
19%
pharmaceuticals
19%
doses
18%
tuberculosis
17%
mycobacterium tuberculosis
17%
epidemiology
15%
isoniazid
14%
detection
14%
investigations
13%
symptoms
13%
data
13%
laboratories
13%
control
13%
antibiotics
12%
resources
12%
cancer
12%
evaluation
12%
pathogenesis
12%
applications
12%
reviews
12%
communities
12%
viruses
11%
tissues
11%
parasites
11%
diagnosis
11%
microscopy
10%
bacteria
10%
hospitals
10%
organs
10%
inflammation
10%
management
10%
size
9%
levels
9%
effusion
9%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Cells
14%
COVID-19
13%
Vaccine Efficacy
13%
Virus
12%
Sample
12%
Lineages
11%
Health
10%
Next Generation Sequencing
9%
Inflammatory Disorder
9%
Hepatitis A
9%
Meropenem/Vaborbactam
9%
Genome Sequencing
9%
Circulation
9%
Breast
9%
Organ
9%
Pholidota
9%
Leishmaniasis
9%
Phylogeny
9%
Halomonas
9%
Inflammation
9%
Immunoregulation
9%
Macromolecule
9%
Molecular Epidemiology
9%
Development
7%
Cladistics
7%
Molecule
7%
Tumor Cell
7%
Hepatitis
6%
Position
5%
Infectious Agent
5%
Comprehension
5%
Keyphrases
Indian Cities
9%
Ujjain
9%
Madhya Pradesh
9%
Bikaner
9%
Hematological Malignancies
9%
Tumor Microenvironment
9%
Hollow Fiber Model
9%
Meropenem-vaborbactam
9%
Omadacycline
9%
Kappa Variant
9%
Potential Biomarkers
9%
Hypersaline Lake
9%
Halomonas
9%
Extracellular Vesicles
9%
Central India
9%
Basti
9%
Uttar Pradesh
9%
Resource Optimization
9%
Targeted Therapy
9%
Eastern Uttar Pradesh
9%
Pharmaceutical Wastewater Treatment
9%
Nanofiltration
9%
Pharmaceutical Wastewater
9%
Wastewater Management
9%
Pooled Testing
6%
High-dose Isoniazid
6%
Tumor Cells
5%
